发明名称 Modified caspase polypeptides and uses thereof
摘要 The technology relates in part to compositions comprising modified Caspase-9 polypeptides, compositions comprising nucleic acids coding for modified Caspase-9 polypeptides, chimeric modified Caspase-9 polypeptides, and methods of use thereof, including methods for cell therapy. Methods for cell therapy include modifying transfused cells to express an inducible modified Caspase-9 protein, with reduced basal activity in the absence of the inducer.
申请公布号 US9434935(B2) 申请公布日期 2016.09.06
申请号 US201313792135 申请日期 2013.03.10
申请人 BELLICUM PHARMACEUTICALS, INC. 发明人 Spencer David;Chang Wei-Chun
分类号 C07H21/04;C12N15/00;C12N15/63;C12N9/64;A61K31/4545;A01K67/00 主分类号 C07H21/04
代理机构 Grant IP, Inc. 代理人 Grant IP, Inc.
主权项 1. A composition comprising a nucleic acid comprising a nucleotide sequence that encodes a chimeric protein comprising a FKBP multimeric ligand binding region and a modified Caspase-9 polypeptide, wherein the modified Caspase-9 polypeptide comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 9, and comprises the amino acid substitution N405Q, wherein a) the chimeric protein has a basal activity less than 50% of the basal activity of a chimeric protein comprising a FKBP multimeric ligand binding region and a Caspase-9 polypeptide lacking the caspase recruitment domain (CARD) and having the amino acid sequence of SEQ ID NO: 9; and b) Caspase-9 activity is induced upon binding of a ligand to the FKBP multimeric ligand binding region of the chimeric protein.
地址 Houston TX US